As with children studies, Supernus ADHD drug shows fast onset of action in adolescents
Positive pivotal data on Supernus’ $SUPN ADHD drug in children gave investors pause earlier this month because of the lack of dose response at the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
